摘要
目的探讨放疗+唑来膦酸对恶性肿瘤骨转移患者的临床治疗效果。方法选取恶性肿瘤骨转移患者48例,随机分为治疗组与对照组各24例,对照组仅接受放疗,治疗组在放疗基础上加用唑来膦酸4mg,每月1次,连用3—6次,3—6个月后评价骨痛缓解情况。结果两组总有效率(83.3%和79.2%)差异无统计学意义(P〉0.05),但治疗组完全缓解(CR)率高于对照组(50.0%和33.3%,P〈0.05)。两组间发热、骨髓抑制、肝肾功能等不良反应差异无统计学意义。结论放疗+唑来膦酸治疗肿瘤骨转移CR率高,生活质量改善较明显,不良反应患者易接受,值得临床应用。
Objective To explore the outcomes of radiotherapy and zoledronic acid in patients with bone me- tastasis. Methods 48 cancer patients with bone metastasis, were divided into two group, control group received radio- therapy only,therapy group received radiotherapy and zoledronic acid. Remission of ostalgia was evaluated after 3-6 months. Results The total effective of remission of ostalgia had no significant differences between two group(83.3% vs 79. 2% , P 〈 0.05 ). But rate of complete remission therapy group was higher than that of control group (50.0% vs 33.3 % ,P 〈 0.05 ). The adverse reaction aer resemble between the two group. Conclusion The outcomes of radio- therapy and zoledronic acid in patients with bone metastasis is effectiveness for cases with bone metastasis, is worth spreading.
出处
《中国基层医药》
CAS
2013年第3期369-370,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
癌
骨转移
唑来膦酸
放疗
Carcinoma
Bony metastasis
Zoledronic acid
Radiotherapy